23 Results

People

  1. Hellmann
    Hellmann
  2. Rudin
    Rudin
  3. Kris
    Kris
  4. Riely
    Riely
  5. Rizvi
    Rizvi
  6. Ladanyi
    Ladanyi
  7. Ni
    Ni
  8. Chaft
    Chaft
  9. Arcila
    Arcila
  10. Drilon
    Drilon

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  2. Biostatistics Service (23)
  3. Department of Medicine (23)
  4. Epidemiology and Biostatistics (23)
  5. GSK Faculty (23)
  6. Solid Tumor Oncology Division (23)
  7. Thoracic Oncology (23)
  8. Human Oncology and Pathogenesis Program (18)
  9. Tow Center for Developmental Oncology (TCDO) (16)
  10. Sloan Kettering Institute Postdocs (15)
  1. "Journal article"
  2. "Biostatistics Service"
  3. "Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center "
  4. "Matthew Hellmann"
Formats
  1. Journal Article (23)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (23)
  2. Biostatistics Service (23)
  3. Department of Medicine (23)
  4. Epidemiology and Biostatistics (23)
  5. GSK Faculty (23)
  6. Solid Tumor Oncology Division (23)

More Groups

People
  1. Matthew Hellmann (23)
  2. Charles Rudin (22)
  3. Mark Kris (16)
  4. Gregory Riely (15)
  5. Marc Ladanyi (15)
  6. Hira Rizvi (13)

More People

Years
  1. 2023 (3)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (5)
  6. 2018 (5)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Annals of Oncology (2)
  3. Cancer Cell (2)
  4. Cancer Discovery (2)
  5. JCO Precision Oncology (2)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. Oxford University Press (4)
  3. American Society of Clinical Oncology (3)
  4. Cell Press (3)
  5. Elsevier Inc. (2)
  6. Nature Publishing Group (2)

More Publishers

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer
    Journal Article

    Schoenfeld, A.; Bandlamudi, C.; Lavery, J. A.; Montecalvo, J.; Namakydoust, A.; Rizvi, H.; Egger, J.; Concepcion, C. P.; Paul, S.; Arcila, M. E.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save